Back to Authors

Kukar, Thomas

https://orcid.org/0000-0002-3750-6262

A5005417427 | I150468666

Mayo Clinic

Emory University

Citations 11

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

Autophagy | March 24, 2021 | Volume: 17 | Issue: 1 | Pages: 1-382

10.1080/15548627.2020.1797280 | PMID 33634751

[O2–18–01]: TDP‐43 PATHOLOGY DISRUPTS NUCLEAR PORE COMPLEXES AND NUCLEOCYTOPLASMIC TRANSPORT IN ALS/FTD

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_12 | Pages: No page available

10.1016/j.jalz.2017.07.247

O2‐03‐01: Insight into the mechanism of gamma‐secretase cleavage: Juxtamembrane amino acids are key to the length of secreted amyloid beta peptide

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2010.05.314

An NSAID-like Compound, FT-9, Preferentially Inhibits γ-Secretase Cleavage of the Amyloid Precursor Protein Compared to Its Effect on Amyloid Precursor-like Protein 1

Biochemistry | October 12, 2009 | Volume: 48 | Issue: 46 | Pages: 10894-10904

10.1021/bi901237k | PMID 19821615

Avoiding Unintended Toxicity

Science | April 30, 2009 | Volume: 324 | Issue: 5927 | Pages: 603-604

10.1126/science.1174267 | PMID 19407192

Drugs that inhibit a distinct form of γ-secretase may be useful in treating Alzheimer's disease without causing harmful side effects.
P2‐461: Selective modulation of gamma‐secretase cleavage of the amyloid precursor family of proteins

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2008.05.1540

P2‐338: Substrate‐targeting gamma‐secretase modulators

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_14 | Pages: No page available

10.1016/j.jalz.2008.05.1415

IC‐P3‐212: Mapping the binding site of gamma‐secretase modulators by small (and not so small) organic molecules

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2008.05.157

P1‐052: Somatic brain transgenic TDP‐43 mice

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2008.05.638

P4–289: Mechanistic insights into the in vitro and in vivo modulation of Aβ42 levels and amyloid pathology by NSAIDS and related compounds

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_20 | Pages: No page available

10.1016/j.jalz.2006.05.2028